Impact of Mixed Chimerism on Myelofibrosis Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation

Biol Blood Marrow Transplant. 2020 Dec;26(12):e301-e302. doi: 10.1016/j.bbmt.2020.09.003. Epub 2020 Sep 17.

Authors

Samer A Srour¹, Uday R Popat²

Affiliations

¹ Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: ssrour@mdanderson.org.
² Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

PMID: 32949752
DOI: 10.1016/j.bbmt.2020.09.003

No abstract available

Publication types

Comment

MeSH terms

Chimerism
Hematopoietic Stem Cell Transplantation*
Humans
Primary Myelofibrosis* / therapy
Transplantation Conditioning